Delivery Order SPE2DX15D1053-SPE2DX24F6LUA
Award Date
5/6/24
Potential Completion Date
5/7/24
Potential Value
$1.3K
Federal Agency
Medical Supply Chain
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $18,466.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order for the pharmaceutical product EUCRISA 2% Ointment, 60 gm, and has a completion date of May 10, 2024. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of EUCRISA 2% ointment, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,529.70, is a firm fixed-price delivery order awarded on April 21, 2023, with an ultimate completion date of April 24, 2023. The contract has no set-aside designation, indicating it was awarded through full and open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,061.92 firm fixed-price delivery order is for the supply of EUCRISA 2% ointment, a pharmaceutical product. The contract has an ultimate completion date of October 31, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA...
This federal contract award, valued at $2,114.10, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EUCRISA 2% ointment, a pharmaceutical product, with a performance period through May 2024. The contract was awarded as a Firm Fixed Price Delivery Order and did not utilize any set-aside requirements, indicating open competition. AmerisourceBergen holds a...
This federal contract award is a delivery order with a firm fixed price of $1,443.41 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of EUCRISA 2% Ointment 60GM, a pharmaceutical product. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, with ID SPE2DB20D2104|SPE2DB23FQ79E, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $6,839.28 delivery order is for the supply of EUCRISA 2% ointment 60GM, a pharmaceutical product. The contract has a completion date of October 21, 2022 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,458.23 firm fixed-price delivery order is for the supply of EUCRISA 2% ointment, a topical medication, to support military healthcare programs. The award is not designated as a set-aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This federal contract award, identified as SPE2DB22D1041|SPE2DB24FUBJ8, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of EUCRISA 2% ointment, a pharmaceutical product, with a ceiling value of $1,655.66 and a completion date of May 10, 2024. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,913.99, is for the delivery of EUCRISA 2% Ointment 60GM, a pharmaceutical product. The contract has an ultimate completion date of September 20, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA...
This federal contract award, SPE2DX15D3402|SPE2DX25F1KDY, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,487.36 firm fixed-price contract is for the delivery of EUCRISA 2% Ointment 60GM, a topical medication. The contract has an ultimate completion date of December 6, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at...